December 2, 2020 Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial Continue reading →
November 18, 2020 Numinus Announces Compassionate Access Trial of Psilocybin-Assisted Psychotherapy for Substance Use Disorders Continue reading →
October 14, 2020 Numinus Appoints Multidisciplinary Global Leaders to its General Advisory Council Continue reading →
September 24, 2020October 2, 2020 Numinus Commences Psilocybe Mushroom Cultivation at its Health Canada Licensed Laboratory Continue reading →
September 11, 2020October 2, 2020 Numinus Announces Closing of Oversubscribed $4.6 Million Offering Continue reading →
June 12, 2020 CORRECTION: Numinus receives Health Canada licence amendment to produce and extract psilocybin from mushrooms Continue reading →